|
Patient composition
|
|
SET
|
5264
|
3082
|
|
DET
|
564
|
301
|
|
Age*, y
|
30.46 ± 4.20
|
30.70 ± 3.94
|
|
Attempt times of IVF*
|
0.95 ± 0.43
|
0.78 ± 0.54
|
|
Antral follicle count*
|
13.64 ± 6.13
|
13.37 ± 6.36
|
|
Follicle stimulating hormone*, IU/L
|
7.59 ± 2.35
|
7.68 ± 2.79
|
|
Luteinizing hormone*, IU/L
|
4.71 ± 3.26
|
4.95 ± 6.08
|
|
E2 per mature oocyte, pmol/L
|
309.60 ± 141.26
|
265.68 ± 133.16
|
|
E2 on HCG day*, pmol/L
|
2810.88 ± 1424.43
|
2174.64 ± 1046.56
|
|
Endometrial Thickness*, mm
|
11.79 ± 2.40
|
11.98 ± 2.55
|
|
MetaphaseII(M II)*
|
9.86 ± 4.14
|
9.25 ± 4.02
|
|
2pronucleus(PN)*
|
6.79 ± 3.35
|
6.31 ± 3.22
|
|
Oocyte Numbera*
|
11.03 ± 4.45
|
10.64 ± 4.49
|
|
2PN/MII*
|
0.70 ± 0.19
|
0.69 ± 0.20
|
|
Frozen Sperm
|
6.0%
|
6.3%
|
|
Male Factorb
|
|
Oligospermia
|
9.2%
|
10.3%
|
|
Asthenospermia
|
12.8%
|
20.0%
|
|
Azoospermia
|
7.1%
|
9.1%
|
|
Female Factorb
|
|
Endometriosis
|
3.0%
|
4.4%
|
|
Ovulation Disorder
|
5.9%
|
7.8%
|
|
Unknown
|
5.2%
|
12.3%
|
|
Sperm Retrieval
|
|
Ejaculation
|
95.2%
|
95.2%
|
|
MESA
|
0.3%
|
0.7%
|
|
TESA
|
1.0%
|
1.3%
|
|
PESA
|
3.5%
|
2.8%
|
|
Stimulation Protocolb
|
|
Agonist Protocol*
|
71.4%
|
70.8%
|
|
Antagonist Protocol
|
22.8%
|
28.5%
|
|
Endometrial Typeb
|
|
A*
|
83.3%
|
85.0%
|
|
B
|
2.0%
|
0.4%
|
|
C*
|
21.4%
|
19.7%
|
|
Infertilityc
|
|
Primary
|
64.9%
|
70.4%
|
|
Secondary*
|
35.1%
|
29.6%
|
|
Fertilization Methodb
|
|
IVF
|
72.5%
|
57.9%
|
|
ICSI*
|
24.5%
|
34.8%
|
|
Embryo Features
|
|
Number of Blastomere*
|
7.93 ± 0.89
|
8.06 ± 0.93
|
|
Fragmentd*
|
0.37 ± 0.50
|
0.32 ± 0.48
|
|
Equalitye*
|
0.91 ± 0.95
|
0.87 ± 0.91
|